Order Article Reprints

Aboelsaad I, Ashmawy R, Mahrous D, Sharaf S, Aly S, Abdullatif S, Fakhry A, Hassan B, Khamis D, Aldakhs A, et al. Clinical Outcomes and Survival Analysis of Remdesivir as a Treatment Option for Moderate to Severe COVID-19 Patients. COVID. 2022; 2(12):1758-1767. https://doi.org/10.3390/covid2120126

Aboelsaad, Iman, Rasha Ashmawy, Doaa Mahrous, Sandy Sharaf, Shahinda Aly, Sara Abdullatif, Ayat Fakhry, Basma Hassan, Dalia Khamis, Alaa Aldakhs, and et al. 2022. "Clinical Outcomes and Survival Analysis of Remdesivir as a Treatment Option for Moderate to Severe COVID-19 Patients" COVID 2, no. 12: 1758-1767. https://doi.org/10.3390/covid2120126

Aboelsaad, I., Ashmawy, R., Mahrous, D., Sharaf, S., Aly, S., Abdullatif, S., Fakhry, A., Hassan, B., Khamis, D., Aldakhs, A., & Kamal, E. (2022). Clinical Outcomes and Survival Analysis of Remdesivir as a Treatment Option for Moderate to Severe COVID-19 Patients. COVID, 2(12), 1758-1767. https://doi.org/10.3390/covid2120126